Jeremy Levin Insider Profile

4 Followers
Jeremy Levin, SVP Strat Transactions at Bristol-Myers Squibb, holds 3.65M shares in Ovid Therapeutics (Ticker: OVID), holds 43.69K shares in Bristol-Myers Squibb (Ticker: BMY). Most recently, Jeremy Levin Bought ― shares of Ovid Therapeutics on Mar 20, 2024 for an estimated value of 50.36K.
tipranks
Jeremy Levin

Jeremy Levin
Bristol-Myers Squibb (BMY)
SVP Strat Transactions

Ranked #15,531 out of 99,218 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+32.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
63.69%
36.31%
A breakdown of Jeremy Levin's holdings

Insider Roles

Ovid Therapeutics
(OVID)
CEO, Director
Bristol-Myers Squibb
(BMY)
SVP Strat Transactions
Roles that Jeremy Levin holds in companies

Most Profitable Insider Trade

Stock:
Ovid Therapeutics
(OVID)
Rating:Informative Buy
Date:Oct 10, 2019 - Oct 10, 2020
Return:+165.20%
The most profitable trade made by Jeremy Levin

Jeremy Levin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bristol-Myers Squibb
Oct 04, 2011
SVP Strat Transactions
Uninformative Buy
147.61K
$2.37M
Ovid Therapeutics
Mar 20, 2024
CEO, Director
Informative Buy
50.36K
$4.16M
List of latest transactions for each holding click on a transaction to see Jeremy Levin's performance on stock

Jeremy Levin insider profile FAQ

What is the percentage of profitable transactions made by Jeremy Levin?
The percentage of profitable transactions made by Jeremy Levin is 50%.
    What is the average return per transaction made by Jeremy Levin?
    The average return per transaction made by Jeremy Levin is 32.40%.
      What stocks does Jeremy Levin hold?
      Jeremy Levin holds: BMY, OVID stocks.
        What was Jeremy Levin’s latest transaction?
        Jeremy Levin latest transaction was an Informative Buy of $50.36K.
          What was Jeremy Levin's most profitable transaction?
          Jeremy Levin’s most profitable transaction was an Informative Buy of OVID stock on October 10, 2019. The return on the trade was 165.20%.
            What is Jeremy Levin's role in Bristol-Myers Squibb?
            Jeremy Levin's role in Bristol-Myers Squibb is SVP Strat Transactions.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.